Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00273377 · ClinicalTrials.gov registry record · Phase 3
The Effects of Hypercapnia, Supplemental Oxygen, and Dexamethasone on Surgical Wound Infection
A Phase 3 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,000
- Enrollment target
NCT00273377 is a Phase 3 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 2,000 participants.
The verdict
NCT00273377, a Phase 3 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,000 participants
- Enrollment target
Study Summary
The investigators will test the hypotheses that mild hypercapnia and supplemental oxygen reduce wound infection risk in patients undergoing colon resection. The investigators will simultaneously test the hypothesis that low-dose dexamethasone (a common treatment for postoperative nausea and vomiting) does not increase infection risk.
Interventions
- DRUG Placebo
- DRUG Dexamethasone
- OTHER Mild intraoperative hypercapnia (50 mmHg vs. 30 mmHg)
- OTHER Supplemental oxygen (80% vs. 30%)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2002-05 |
| Est. Completion | 2007-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00273377
The ClinicalTrials.gov registry entry for NCT00273377 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00273377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00273377 about?
NCT00273377 is a clinical study titled "The Effects of Hypercapnia, Supplemental Oxygen, and Dexamethasone on Surgical Wound Infection". The investigators will test the hypotheses that mild hypercapnia and supplemental oxygen reduce wound infection risk in patients undergoing colon resection. The investigators will simultaneously test the hypothesis that low-dose dexamethasone (a common treatment for postoperative nausea and vomiting...
What is the current status of trial NCT00273377?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,000 participants. The study started on 2002-05. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00273377?
The interventions under investigation include: Placebo (DRUG), Dexamethasone (DRUG), Mild intraoperative hypercapnia (50 mmHg vs. 30 mmHg) (OTHER), Supplemental oxygen (80% vs. 30%) (OTHER).
Who is sponsoring clinical trial NCT00273377?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.